Linkus syrup sugar free syrup

País: Armênia

Língua: inglês

Origem: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes ativos:

adhadota vasica, glycyrrhiza glabra, piper longum, viola odorata, hyssopus officinalis, alpinia galanga, cordia latifolia, altaea officinalis, zizyphus vulgaris, onosma bracteata

Disponível em:

Herbion Pakistan Pvt. Ltd.

Código ATC:

R05CA10

DCI (Denominação Comum Internacional):

adhadota vasica, glycyrrhiza glabra, piper longum, viola odorata, hyssopus officinalis, alpinia galanga, cordia latifolia, altaea officinalis, zizyphus vulgaris, onosma bracteata

Dosagem:

60mg/ml+ 7,5mg/ml+ 10mg/ml+ 2,5mg/ml+ 5mg/ml+ 5mg/ml+ 10mg/ml+ 10mg/ml+ 10mg/ml+ 10mg/ml

Forma farmacêutica:

syrup

Unidades em pacote:

glass bottle 90ml, glass bottle 120ml, glass bottle 150ml

Tipo de prescrição:

OTC

Status de autorização:

Registered

Data de autorização:

2019-06-19

Características técnicas

LINKUS SYRUP SUGAR FREE
BRIEF CHARACTERISTIC OF MEDICAL PREPARATION
1.
NAME OF PREPARATION
Linkus
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH 10 ML OF LINKUS SYRUP CONTAINS DRY EXTRACTS OF:
_Active ingredients: _
Adhatoda vasica 600 mg, Onosma bracteatum 100 mg, Piper longum 100 mg,
Cordia latifolia
100 mg, Althea officinalis 100 mg, Zizyphus vulgaris 100 mg,
Glycyrrhiza glabra 75 mg,
Alpinia galanga 50 mg, Hyssopus officinalis 50 mg, Viola odorata 25
mg.
_FOR EXCIPIENTS, SEE 6.1. _
3.
MEDICINAL FORM
Syrup sugar free;
4.
CLINICAL CHARACTERISTICS
4.1.
THERAPEUTIC INDICATIONS
Symptomatic therapy of infectious-inflammatory diseases of the
respiratory tract
accompanied by cough with hardly expectorated sputum (against the
background of acute
respiratory diseases, flu, tracheitis, bronchitis, tracheobronchitis,
pneumonia,
bronchitis of
smokers
and other inflammatory diseases of the respiratory tract).
4.2.
DOSAGE AND ADMINISTRATION
For oral use!
Children from 12 to 18 years: 1 teaspoonful 4 times daily
Adult: 2 teaspoons 3 – 4 times daily
Duration of treatment course: 5-7 days.
Extention of duration and conduct of repeated courses of treatment is
possible on the
recommendation of a doctor.
4.3.
CONTRAINDICATIONS:
Hypersensitivity to any of the components of the product.
4.4.
SPECIAL INSTRUCTIONS AND SPECIAL SAFETY MEASURES
Use with caution when lactic acidosis (since composition includes
sorbitol)
Syrup contains methyl parahydroxybenzoate and propyl
parahydroxybenzoate, which can
cause allergic reactions (possible delayed).
Patients with rarely inherited fructose intolerance should not take
this drug.
_ _
4.5.
DRUG AND OTHER FORMS OF INTERACTIONS:
Concomitant use with other antitussive preparations and preparations
which decrease
expectorations is not recommended.
4.6. IMPACT ON ABILITY TO DRIVE OR PERFORMING HAZARDOUS TASKS:
Not revealed.
4.7.
SIDE EFFECTS:
Rarely- allergy reaction
4.8.
OVER DOSAGE:
Not revealed.
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES
Complex ayurvedi